MAR 11, 2016 8:14 AM PST

Macrophages Break Down Protective Barrier of Pancreatic Tumors

WRITTEN BY: Kara Marker
In 2016, the five-year survival rate for pancreatic cancer increased from seven to eight percent (American Cancer Society). Not a monumental increase, but scientists are still working on therapies to get the numbers even higher.

Scientists from the Abramson Cancer Center University of Pennsylvania School of Medicine, in their new preclinical study published in the journal Cancer Discovery, investigated the potential of macrophages to break down protective walls around pancreatic tumors, also known as their microenvironment. They found that sending certain signals to macrophages with an experimental immune therapy can be successful in influencing them to strip away the protective parts that pancreatic tumors use to evade the harsh chemicals of chemotherapies.
 


“We’ve learned how antibodies that target a cell surface molecule called CD40 work with the immune system to tear back that wall,” said study leader Gregory Beatty, MD, PhD. Plus, the same antibodies were found to actually enhance the effect of chemotherapy once the tumor’s defenses were stripped away.

The ACC study recently published followed a previous study by the same researchers. In 2011 they illustrated the ability of CD40 to prompt monocyte and macrophage populations to destruct the tumor microenvironment. However, until their newest study, the team couldn’t pinpoint the precise mechanism behind the connection between CD40 and the immune cells.

Their new study involved mouse models of pancreatic cancer, and they were able to identify two immune factors released after CD40 antibody treatment. The suspects are chemokine ligand 2 (CCL2) and interferon gamma. While CCL2 recruits macrophage tumor infiltration, interferon-gamma prompts macrophages to release enzymes called metalloproteinases, which degrade the “fibrotic scaffold” of the tumor microenvironment, the structure that protects the cancerous cells from destruction by chemotherapy.

The tag team effort of CCL2 and interferon-gamma, as a result of CD40 antibody stimulation, leads to fibrosis degradation, identified by the scientists as the final blow in breaking down the tumor defenses.

While this discovery is promising in the fight against pancreatic cancer, the research team also realized that the timing of CD40 treatment followed by chemotherapy is extremely critical: too soon and patients are at risk for a 30 percent mortality rate, and too late and the chemotherapy is ineffective. They found that the “sweet spot” for chemotherapy delivery is five days post-CD40 treatment, where they saw the treatment well-tolerated and tumor cells shrinking and dying.

“Macrophages can be very potent killers of cancer,” Beatty said. “Since keeping them out of tumors is a challenge, why not harness their recruitment?”
 

Source: University of Pennsylvania School of Medicine
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 07, 2020
Neuroscience
FEB 07, 2020
Eating Fruits and Vegetables May Lower Alzheimer's Risk
New research has found that flavonols, a large class of compounds present in many fruits and vegetables, may be linked t ...
MAR 19, 2020
Infographics
MAR 19, 2020
All You Need to Know About Coronavirus (CoVID-19)
A new coronavirus, first identified in China in December 2019, has caused an outbreak of respiratory illness that was re ...
MAR 28, 2020
Drug Discovery & Development
MAR 28, 2020
FDA Approves 5-Minute Coronavirus Test
In recent weeks, the US has struggled to supply enough tests to detect the coronavirus. Now, however, this may change th ...
APR 13, 2020
Immunology
APR 13, 2020
Macrophages: An Origin Story
Macrophages are well-known defense cells of the immune system, responsible for utilizing the cellular breakdown process ...
APR 21, 2020
Cancer
APR 21, 2020
Scientists develop tumor immunity map
A new study published in eLife describes the findings from a study that has successfully mapped tumor cell molecule ...
MAY 12, 2020
Immunology
MAY 12, 2020
Disabling Genes in Immune Cells Prevents Obesity
Obesity is a $1.7 trillion problem in the United States — a value almost 10% of the nation’s gross domestic ...
Loading Comments...